CMO 360 Summit Boston

Executive Sponsor & Speaker.

The CMO Summit 360°® is the largest gathering of biotech Chief Medical Officers across indications,
modalities, company stages, professional experience levels and geographic locations.
Missing image

Arriello’s Chief Regulatory Officer Peter Embley was speaking at the biotech focused Chief Medical Officer Summit 360° event in Boston April 3–4.

Pete was talking about multi-regional regulatory strategies to enable successful early drug development, including the application of early regulatory engagement in Europe & UK, the benefits of regulatory alignment across EMA, FDA & UK, and picking the right time to build your Regulatory, PV and Quality teams.

Missing image

Principal Commercial Consultant Matt Smith was on-hand to discuss any upcoming project needs.

Matt has 25 years experience in Business development and strategy consultation for all phases of pharmaceutical development from concept to commercialization; contract negotiation, formation and management.

Missing image

Principal Consultant Jayne Hunt joined to leverage her experience in areas like marketing authorizations and pre-marketing development activities.

Jayne has over 30 years strategic & operational Regulatory Affairs expertise in pre & post marketing across the EU, UK, US, and other territories.

Find out more about the CMO Conference:

Latest News

The benefits of using Veeva Vault Safety, for us, it means that we are able to use their reporting capabilities directly from the safety database. We are able to use the gateway connection with the regulatory authorities and with partners.
Arriello modernizes pharmacovigilance with Veeva Vault Safety.
Kieran and Nicola speaking about our latest US/UK/EU survey which provides initial feedback from senior PV and Reg professionals across 4 countries on the EMA’s new Clinical Trials Regulation (CTR) that will be fully applicable from January 31 2023.
BIO Europe 2022: Fireside chat about CTR/CTIS.
Peter Embley joins Arriello to lead it’s Regulatory Affairs team and comes with over 24 years of experience working across the Pharmaceutical, CRO and Consulting Industries.
Peter Embley appointed as Chief Regulatory Officer.